On Friday, healthcare stocks were the top losers with British drugmaker GSK down 4.6 per cent after a US FDA advisory panel ...

In a 10-1 vote, the U.S. FDA’s Psychopharmacologic Drugs Advisory Committee said Otsuka Pharmaceutical Co. Ltd.’s studies of its combination post-traumatic stress disorder (PTSD) treatment did not ...